🔎 Trials Near Me

Gara Jalqabaatti › Obesity › Kansas › Wichita

Qorannoo klinikaalii Obesity Wichita, KS keessatti

Qorannoo 11 Obesity f Wichita fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Namoota walitti qabaa jiraSadarkaa 2
  • AMR Clinical - Wichita, Wichita
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07685808

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Newton · Miili 24 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07784270

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Namoota walitti qabaa jiraSadarkaa 3
  • AMR Clinical, Newton · Miili 24 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07353931

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Kansas Nephrology Research Institute LLC, Wichita
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07037459

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
  • ACCOMPLISH-2 Research Site, Wichita
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Kailera Clinical Site, Newton · Miili 24 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Namoota walitti qabaa jiraSadarkaa 3
  • Alliance for Multispecialty Research Newton, Newton · Miili 24 fagaatti
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Namoota walitti qabaa jiraSadarkaa 3
  • Alliance for Multispecialty Research LLC, Wichita
  • Alliance for Multispecialty Research Newton, Newton · Miili 24 fagaatti
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Kailera Clinical Site, Newton · Miili 24 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT07284979

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • West Houston Area Clinical Trial Consultants, Wichita
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Namoota walitti qabaa jiraSadarkaa 3
  • ACCOMPLISH-1 Research Site, Wichita
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07654361

Qorannoo Obesity magaalota biroo keessatti

Qorannoo biroo Wichita keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.